Artificial Cells, Nanomedicine and Biotechnology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.6 | Q1 | 79.4% | 0.967 | Q1 | 83.0% |
| 2024 | 4.5 | Q1 | 80.2% | 0.739 | Q1 | 75.4% |
| 2023 | 4.5 | Q2 | 58.5% | 0.646 | Q2 | 73.2% |
| 2022 | 5.8 | Q1 | 70.0% | 0.764 | Q1 | 79.3% |
| 2021 | 6.4 | Q2 | 71.8% | 0.884 | Q1 | 83.8% |
| 2020 | — | — | 0.935 | Q1 | 83.8% | |
| 2019 | — | — | 0.577 | Q2 | 71.5% | |
| 2018 | — | — | 0.582 | Q2 | 69.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2169-1401
ISSN
2169-141X
country
GBcoverage
2013-2026